U.S. federal trademark · Serial No. 97514050 · Reg. No. TMA1416766
Pharmaceutical preparations for use in the prevention and the treatment of cancer, rare autoimmune diseases and disorders, autoimmune diseases and disorders, liver diseases, biliary diseases, namely bile ducts and gallbladder, metabolic diseases, namely diabetes, hypoglycemia, gout, arthritis, muscular dystrophy and anemia, inflammatory diseases namely, inflammatory bowel diseases, enteric diseases and inflammatory connective tissue diseases, urological diseases, disorders and diseases of the reproductive system namely, sexual reproduction and fertility, puberty diseases or disorders, namely, precocious puberty, gynecological disorders namely, menstrual irregularities and menopause-related diseases and symptoms, namely, anemia, fertility, acromegalia and tumors, hormonal disorders; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the endocrine system, namely, glucagonoma, growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management, inflammatory connective tissue diseases, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, namely, epilepsy, multiple sclerosis, headache, brain tumors, Parkinson's disease, Huntington's disease, Alzheimer's disease, dementia; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome; pharmaceutical preparations and substances for the prevention and treatment of pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin namely, acne, rosacea, dermatitis, psoriasis, vitiligo, hives, alopecia areata, Lupus; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutinin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified component of the toxin haemagglutinin complex for skin care and the treatment of neurological disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.